Tamiflu use extended

The lower age limit for use of Tamiflu (oseltamivir) has been reduced from one year to six months of age when treating flu during a pandemic. Prophylactic use of the drug is not recommended under one year. The capsule SPCs now also provide instructions for preparing extemporaneous oral 10mg/ml or 15mg/ml solutions from capsules when the powder for oral suspension is unavailable.

View Tamiflu drug record

Further information: Roche


To sign up for the MIMS monthly news update, register at www.mims.co.uk/bulletins.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

An empty tablet blister pack.

Ezetimibe supply update

Availability issues have been reported for the lipid-lowering...

Woman holding blister strip of contraceptive pills

Pharmacists across England to initiate oral contraceptives

Pharmacy Contraception Service (PCS) could allow almost...